Table 1 Quality assessment checklist for randomized controlled trials (Critical Appraisal tools for use in JBI Systematic Reviews)
From: Powered single hip joint exoskeletons for gait rehabilitation: a systematic review and Meta-analysis
N | Criteria | Jayaraman (2018) | Ji (2018) | Kawasaki (2014) | Martini (2019) | Tanaka (2017) | Buesing (2015) | Hwang-Jae Lee (2019) |
|---|---|---|---|---|---|---|---|---|
1 | Was true randomization used for assignment of participants to treatment groups? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
2 | Was allocation to treatment groups concealed? | Unclear | Unclear | No | Unclear | No | No | Unclear |
3 | Were treatment groups similar at the baseline? | Yes | Yes | NA | No | Yes | Yes | Yes |
4 | Were participants blind to treatment assignment? | No | No | No | No | No | No | No |
5 | Were those delivering treatment blind to treatment assignment? | No | Unclear | No | Unclear | No | No | Unclear |
6 | Were outcomes assessors blind to treatment assignment? | Yes | Unclear | No | Unclear | No | Yes | Unclear |
7 | Were treatment groups treated identically other than the intervention of interest? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
8 | Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analyzed? | Yes | Yes | Yes | Yes | Yes | Yes | NA |
9 | Were participants analyzed in the groups to which they were randomized? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
10 | Were outcomes measured in the same way for treatment groups? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
11 | Were outcomes measured in a reliable way? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
12 | Was appropriate statistical analysis used? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
13 | Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial? | Yes | Unclear | No | Yes | Yes | Yes | Yes |